BioLine RX Ltd ADR buy stratec
Start price
08.12.17
/
50%
€223.25
Target price
03.12.18
€608.85
Performance (%)
-36.36%
End price
03.12.18
€142.07
Summary
This prediction ended on 03.12.18 with a price of €142.07. The BUY prediction by stratec for BioLine RX Ltd ADR performed very badly with a performance of -36.36%. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioLine RX Ltd ADR | -3.279% | -3.279% | -56.296% | -77.481% |
iShares Core DAX® | 0.051% | 5.593% | 14.403% | 19.767% |
iShares Nasdaq 100 | 1.808% | 7.445% | 34.917% | 57.237% |
iShares Nikkei 225® | 2.181% | 2.815% | 11.116% | 8.873% |
iShares S&P 500 | 1.040% | 4.975% | 27.631% | 48.786% |
Comments by stratec for this prediction
In the thread BioLine RX Ltd ADR diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 08.12.2017 der Buy-Einschätzung von tamam mit dem Kursziel 3$ zu.Überschrift: BioLineRx in partnership with Novartis and collaboration with Roche
(Vom Mitglied beendet)
Stopped prediction by stratec for BioLine RX Ltd ADR
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€142.07
02.12.18
02.12.18
€45.00
12.05.20
12.05.20
-98.91%
12.05.20
12.05.20